Reporte zur Charge U1F962V

Symptomtext

Off Label Use; Initial information received on 27-Dec-2022 regarding an unsolicited valid non-serious case received from a consumer/non-hcp. This case is linked to cases 2022SA523303(CLUSTER) and 2022SA523303(CLUSTER). This case involves a 52 years old male patient who experienced off label use while receiving vaccines RABIES (VERO) VACCINE [VERORAB] and IPV (VERO) [IMOVAX]. The patient's past medical treatment included SHINGRIX on 01-DEC-2022. The patient's past medical history, vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect IPV (VERO) lot number not reported. On 20-Dec-2022, the patient received a dose 1 dose of suspect RABIES (VERO) VACCINE lot U1F962V via unknown route in the right arm. On 23-Dec-2022 he also received a dose 2 dose of the same vaccine lot U1F962V via unknown route in the left arm for dog bite. On 27-DEC-2022 the patient developed a non-serious off label use (unknown latency) following the administration of IPV (VERO) and 7 days following the administration of RABIES (VERO) VACCINE. Action taken: was not applicable. It was not reported if the patient received a corrective treatment for the event (Off Label Use). At time of reporting, the outcome was Unknown for the event off label use.